What Is Type 5 Collagen and What Does It Do?

Type V collagen is a fibril-forming protein found throughout connective tissues, where its primary job is regulating how collagen fibers are built. It does not do the heavy structural lifting on its own — that role belongs mainly to type I collagen, which is far more abundant. Instead, type V collagen acts as a kind of organizer, controlling the diameter and architecture of collagen fibrils by co-assembling with type I collagen into mixed fibers. This regulatory function turns out to have outsized consequences for skin integrity, corneal transparency, tendon strength, heart repair, and even organ transplant outcomes.

How Type V Collagen Controls Fiber Assembly

Your body’s connective tissues are built on collagen fibers, and the vast majority of those fibers are made primarily of type I collagen. Type V collagen makes up a small fraction of the total — often just a few percent — yet its influence on fiber formation is disproportionately large. In laboratory experiments, mixing type I collagen with increasing amounts of type V collagen progressively shrinks the diameter of the resulting fibers. The amino-terminal end of the type V collagen molecule is responsible for this diameter-regulating effect; without it, the shrinking activity largely disappears.¹ The fibers that form are heterotypic, meaning they contain both collagen types woven together rather than existing as separate populations.

But type V collagen does more than just trim fiber width. It appears to be required for fibers to form at all. Mice engineered to completely lack type V collagen show a near-total absence of collagen fibril formation, which is lethal. Mice with only one working copy of the relevant gene survive but have about half the normal number of fibrils in their skin, along with a second population of abnormally large, structurally disordered fibers.² This tells us type V collagen serves as a kind of nucleation seed: it is the scaffold on which fiber assembly begins, and without enough of it, the process goes haywire.³

Where It Shows Up in the Body

Type V collagen is widespread but not evenly distributed. In normal human skin, it shows up throughout the dermis, with particularly strong concentrations in the papillary dermis (the upper layer closest to the surface) and around hair follicles and sweat glands. It is found in the connective tissue between cells rather than in basement membranes, placing it squarely in the interstitial matrix.⁴

It also exists in at least three different molecular forms, built from combinations of three possible protein chains called α1(V), α2(V), and α3(V). The most common form in most tissues is made of two α1 chains and one α2 chain. The α3(V) chain, until recently less studied, is produced abundantly by the basal keratinocytes in skin and in the outer root sheath of hair. Its expression declines with age and drops as skin cells differentiate, which hints at a role in maintaining the skin’s youthful structure.⁵ Beyond skin, type V collagen is present in tendons, ligaments, bone, blood vessel walls, the cornea of the eye, lung tissue, and the placenta.

Why the Cornea Needs It So Badly

The cornea is one of the most collagen-dense tissues in the body, and its transparency depends on having extremely uniform, small-diameter collagen fibrils packed in precise, regular arrays. Type V collagen concentrations are unusually high in the cornea compared to most other tissues, and that is not a coincidence. When researchers experimentally reduced type V collagen levels in corneal tissue, the fibrils that formed were abnormally large and varied wildly in diameter, characteristics similar to what you see in connective tissues that naturally have low type V concentrations, like tendon or bone.⁶

The amino-terminal domain of type V collagen, the same part responsible for diameter regulation in other tissues, was found associated with the small-diameter fibrils in the cornea but absent from the abnormally large ones. The practical takeaway: type V collagen is a key reason the cornea can be transparent. Without it dictating uniform fibril size, light would scatter instead of passing cleanly through, and vision would be compromised.

The Link to Ehlers-Danlos Syndrome

The clearest human disease connection for type V collagen is classical Ehlers-Danlos syndrome (EDS), a heritable condition characterized by skin that stretches too far, joints that bend too much, easy bruising, and abnormal scarring. A comprehensive analysis of 126 patients found type V collagen defects in over 90% of those who met all the major clinical criteria for the diagnosis, with mutations in the COL5A1 gene being the most common, followed by COL5A2 mutations.⁷ A separate study of 40 patients identified 18 novel COL5A1 mutations and 2 COL5A2 mutations, with the majority leading to a situation where the affected gene simply stops producing its protein chain altogether.⁸

This loss-of-function pattern is described as haploinsufficiency: patients have one working copy and one broken copy of the gene, and the single working copy does not produce enough type V collagen to maintain normal fiber assembly. Researchers estimate roughly a third of classical EDS patients have this specific type of mutation, where one COL5A1 allele is essentially silenced.⁹ The consequence is exactly what you would predict from the animal studies: without enough type V collagen to properly regulate fiber formation, collagen fibrils in the skin and other tissues become disorganized and structurally abnormal, producing the hallmark tissue fragility of the disease.¹⁰

What This Means for Tendons and Joints

People with classical EDS often deal with recurring joint dislocations, which raises the question of whether the problem is purely in the skin or extends to the mechanical tissues holding joints together. Studies using mice with targeted deletion of COL5A1 in tendons found that maximum load-bearing capacity and stiffness were reduced across multiple tendon and ligament types, though the effect varied by tissue.¹¹ The joint instability that classical EDS patients experience is likely caused in part by these weakened tendons and ligaments, not just by overly stretchy skin. The tissue-dependent nature of the effect also explains why some joints are more problematic than others for individual patients.

Heart Scars and the Paradox of Missing Collagen

After a heart attack, scar tissue replaces dead heart muscle. You might assume that less collagen in a scar means a smaller scar, but type V collagen flips that logic. In the normal heart, type V collagen is barely present. It gets deposited into scar tissue after injury, where it acts as one of the earliest fibrillar collagens laid down, arriving alongside immune cells called macrophages before the main scar-producing fibroblasts even activate.¹²

When researchers deleted the COL5A1 gene specifically in macrophages, the collagen fibrils in the forming scar were misaligned and disarrayed, with trends toward thinning of the heart wall and reduced cardiac function. A broader study found an even more counterintuitive result: animals lacking type V collagen in scar tissue altogether developed significantly larger scars after heart injury, not smaller ones. The mechanism involves mechanical feedback. Without type V collagen to give the scar its normal stiffness, the altered mechanical properties of the scar drive fibroblasts to keep producing more matrix material, resulting in excessive scarring.¹³ This is a striking example of how type V collagen’s organizational role extends well beyond simply building fibers — it shapes the mechanical environment that cells respond to.

An Unexpected Role in Transplant Rejection

Organ transplant rejection is usually understood as the recipient’s immune system attacking foreign tissue. But research on lung transplantation has revealed that type V collagen can become a target of an autoimmune response, meaning the body attacks its own protein. In normal, healthy lungs, type V collagen is buried within fibers and largely hidden from the immune system. During the tissue damage that accompanies rejection, type V collagen fragments become exposed, and the immune system can mount a T cell response against them.¹⁴

Because type V collagen is highly conserved across individuals (it looks the same whether the protein came from the donor or the recipient), the immune reaction against it is not a foreign-tissue response but a self-directed one. This means transplant rejection involves both the expected response against the donor organ and an autoimmune component targeting the recipient’s own collagen. Inducing oral tolerance to type V collagen in animal models prevented both acute and chronic rejection, which has opened a line of research into whether dampening this autoimmune arm could improve transplant outcomes in humans.¹⁵

Type V Collagen in Cancer

Tumors do not grow in isolation — they interact constantly with the surrounding tissue, including the structural proteins of the extracellular matrix. Type V collagen shows up in altered amounts in several cancer types, and the pattern matters. In normal breast tissue, type V collagen makes up less than 0.1% of interstitial collagens. In the dense, fibrous stroma that forms around invasive breast tumors (called desmoplasia), that proportion jumps to around 10%, a roughly hundredfold increase. The type V collagen is not being made by the cancer cells themselves but by specialized cells in the surrounding stroma, likely myofibroblasts recruited in response to the invading tumor.¹⁶

In lung adenocarcinoma, high expression of COL5A1 by myofibroblasts has been associated with increased tissue mechanical stress, which in turn promotes tumor invasiveness and activates pathways linked to metastasis and therapy resistance.¹⁷ The way type V collagen is organized around tumor cells appears to matter as much as how much of it there is. Different structural patterns of type V collagen create different microenvironments for tumor invasion across cancer types, with prognostic implications: the distribution pattern can help predict how aggressively a tumor is likely to behave.¹⁸

A Potential Biomarker for Liver Fibrosis

When the liver is scarring (fibrosis), the extracellular matrix is being actively remodeled, and type V collagen production increases as part of that process. Researchers have developed a blood test targeting a specific fragment of type V collagen — a neoepitope from the C-terminal propeptide of the α2(V) chain, designated P5CP — that can be measured with a simple antibody-based assay. In animal models of liver fibrosis, serum levels of this fragment tracked closely with the amount of collagen being deposited in the liver, rising progressively from early fibrosis through end-stage cirrhosis.¹⁹ The appeal of this approach is that it could offer a noninvasive way to monitor fibrosis progression, potentially replacing or supplementing liver biopsies, though clinical validation in human patients is still ongoing.

Skin Aging and the α3(V) Chain

While most research on type V collagen has focused on the α1(V) and α2(V) chains, the α3(V) chain has recently drawn attention in dermatology. In human skin, α3(V) collagen is produced mainly by basal keratinocytes and declines with age, paralleling the general loss of collagen structure in aging skin. Silencing α3(V) collagen in keratinocytes leads to increased expression of MMP-9, a matrix-degrading enzyme implicated in skin aging and inflammatory skin conditions like eczema. On the flip side, retinoic acid — the active form of vitamin A and a cornerstone of anti-aging skincare — stimulates α3(V) collagen expression both in cultured cells and in human skin tissue samples.⁵ This finding suggests that part of retinoid therapy’s benefit for skin may work through restoring type V collagen levels, and it opens a door toward treatments that specifically target the α3(V) chain for anti-aging or eczema applications.

An Evolutionarily Ancient Protein

Type V collagen is not a recent evolutionary innovation. Researchers studying collagen genes in organisms as distant as sponges and sea anemones found that the modular structure characteristic of type V (and the closely related type XI) collagen has been conserved from sponges all the way to humans. While other collagen family members have shuffled their building blocks over evolutionary time, the type V/XI lineage has maintained its architecture across hundreds of millions of years.²⁰ This deep conservation is consistent with its role as a fiber-assembly initiator: if you are the molecule that other collagens depend on to start building fibers in the first place, there is very little room for your structure to drift. It is one of the oldest organizational tools in the animal kingdom’s construction kit.

Processing the Molecule

Like most collagens, type V collagen is initially produced as a larger precursor (procollagen) that needs to be trimmed before it can function. One detail that distinguishes type V collagen from its more abundant cousin, type I, is that it retains large portions of its amino-terminal propeptide even after processing. This retained domain is the very region responsible for regulating fibril diameter — it protrudes from the surface of assembled fibers and physically constrains how large they can grow. The enzymatic processing itself involves a protease called BMP-1, and its activity on the α1(V) chain is boosted by an enhancer protein called PCPE-1.²¹ This is a tightly regulated step, because how much of the propeptide gets removed affects how strongly type V collagen can constrain fiber size in different tissues.